Latest Us Expansion News

Page 1 of 32
Knosys is asking shareholders for up to $4.3 million to move its Libero library software from product development into a staged US commercial launch. The non-underwritten raising will fund a lean local team, anchor customers, procurement access and the planned March 2027 release of Libero 7.
Sophie Babbage
Sophie Babbage
18 Nov 2026
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026
Smart Parking has posted record FY26 revenue of $126.0 million and adjusted EBITDA of $30.8 million, while setting a target of 3,000 ANPR sites by December 2028. The next phase will require the company to turn US investment, acquisitions and regulatory progress into sustained site growth.
Victor Sage
Victor Sage
13 Nov 2026
Artrya has signed its first inbound US customer outside its foundation and research relationships, securing a five-year HonorHealth agreement with a minimum value of US$0.5 million. The Salix platform will be deployed across the Arizona health system’s nine-hospital CCTA network.
Victor Sage
Victor Sage
13 Nov 2026
Anteris Technologies reported a wider third-quarter loss as spending accelerated on its PARADIGM heart-valve trial and manufacturing expansion. The company ended September with US$236.3 million in cash, but also retained unresolved weaknesses in financial reporting controls.
Ada Torres
Ada Torres
11 Nov 2026
QuickFee’s Q1 FY27 revenue held at A$4.2 million on a normalised basis, while US loan originations rose 15% and Australian transaction values slipped. The lender maintained FY27 EBTDA guidance at A$4.5 million to A$5.0 million despite lower net interest margins and softer SME conditions.
Claire Turing
Claire Turing
6 Nov 2026
Janus Electric has mapped out an expansion across five US regions and Western Australia after building a 124-truck North American order book worth approximately A$64.6 million gross. The company reiterated FY27 revenue guidance of A$70 million to A$100 million, but delivery remains dependent on incentives, financing, battery supply and execution.
Victor Sage
Victor Sage
4 Nov 2026
Nodestream has completed its $6.5 million placement, launched Missions and expanded its defence push across the US and Europe. But revenue remains under pressure, quarterly cash burn is substantial and auditors have warned of material uncertainty over the company’s ability to continue as a going concern.
Sophie Babbage
Sophie Babbage
2 Nov 2026
Noronex has completed its Sleitat tin project acquisition and expanded the mapped Alaskan greisen system beyond one kilometre, but the explorer ended September with A$1.135 million and only 1.28 quarters of estimated funding. Assay results, South32-backed drilling and a potential capital raise now sit alongside the company’s exploration ambitions.
Maxwell Dee
Maxwell Dee
30 Oct 2026
HITIQ has expanded its military research ambitions and added fresh funding during the September quarter, but the company ended the period with $658,242 in cash and estimated funding for only one quarter. Its US collaboration remains non-binding, leaving financing and commercial execution as the immediate tests.
Victor Sage
Victor Sage
30 Oct 2026
Decidr AI Industries reported a sharp quarterly fall in its invoicing-based AER, even as customer receipts reached a record and Sugarwork’s qualified pipeline expanded. The company is relying on A$11 million of annualised cost reductions and upcoming product launches to extend its runway and convert enterprise interest into recurring revenue.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Vitasora Health has signed a Florida healthcare agreement covering an initially addressable 9,000 Medicare patients while estimated October billable care minutes rose 50%. The ASX-listed company also agreed terms for an A$3 million secured facility, but the funding is not yet drawn and carries approval, interest and dilution conditions.
Ada Torres
Ada Torres
30 Oct 2026

Browse the archive

Full archive